When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.

3. Cigna to remove AbbVie's Humira from some drug ... - AOL

   www.aol.com/news/cigna-remove-abbvies-humira...

   Cigna said on Monday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement in 2025, and recommend less pricey ...

4. CVS will remove AbbVie's Humira from some drug ... - AOL

   www.aol.com/news/cvs-remove-abbvies-humira-drug...

   CVS Health said on Wednesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of April 1, and will recommend ...

5. UnitedHealth to remove AbbVie's Humira from some US drug ...

   www.aol.com/news/unitedhealth-remove-abbvies...

   The U.S. market share for Humira biosimilars stands at nearly 20%, compared with 2.2% in the first quarter of this year, Barclays analysts said in a note on Monday.

6. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   inflammatory bowel disease, ulcerative colitis, Crohn's disease: Actoxumab [6] mab: human: Clostridioides difficile: Clostridioides difficile colitis: Adalimumab [7] Humira: mab: human: TNF-α: Y [8] rheumatoid arthritis, Crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic ...

7. Disease-modifying antirheumatic drug - Wikipedia

   en.wikipedia.org/wiki/Disease-modifying_anti...

   The term "antirheumatic" can be used in similar contexts, but without making a claim about an effect on the disease course. [3] Other terms that have historically been used to refer to the same group of drugs are "remission-inducing drugs" (RIDs) and "slow-acting antirheumatic drugs" (SAARDs).